McKesson to acquire Rexall for $1.9 billion
TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $1.9 billion ($3 billion Canadian). McKesson and Katz Group said Wednesday that the deal will strengthen McKesson’s position in Canada’s pharmaceutical supply chain and is described as a natural step for two companies that have worked together for